Diagnosis and management of shrimp allergy
Bin Su, Warren Blackmon, Chunping Xu, Christopher Holt, Nathaniel Boateng, D Wang, Vibha Szafron, Aikaterini Anagnostou, Sara Anvari, Carla M. Davis
Abstract
Shrimp allergy, the most common food allergy in the United States, affects up to 2% of the population. Its etiology is multi-factorial with the combination of genetic predisposition and environmental exposures. This review summarizes the latest diagnosis and management strategies for shrimp allergy. Currently, the double-blind, placebo-controlled food challenge is the gold standard for diagnosis. Moreover, mainstream and experimental management strategies include food allergen avoidance, the FDA-approved omalizumab, and oral immunotherapy. Herein, we emphasize the urgent need to develop more effective diagnostic tools and therapies for shrimp allergy.